A traditional Chinese medicine composition for secondary prevention after PCI of acute coronary syndrome

Abstract

The invention relates to a traditional Chinese medicine composition used for secondary prevention of acute coronary syndrome after PCI. 1.3 parts, 10 parts of Danshen, 4 parts of Yinhua. The present invention also includes the application of the traditional Chinese medicine composition in the preparation of secondary prevention medicine for acute coronary syndrome after PCI. In the prescription, the fairy spirit spleen warms and invigorates the innate kidney essence as the monarch drug; Radix Pseudostellariae tonifies the heart qi, and helps the monarch medicine to strengthen the effect as the minister drug; leech and salvia miltiorrhiza reduce phlegm and blood stasis to dredge the heart collaterals, and honeysuckle clears heat and detoxifies as the adjuvant drug , the whole prescription treats the heart and kidney at the same time, mainly tonifying, taking tonifying as the way, tonifying and tonifying, tonifying but not obstructed, and tonifying without damage. It has the effects of warming the kidney yang, nourishing the heart, eliminating phlegm and blood stasis, and dredging the heart and collaterals . The experimental results show that this formula is used for this type of patients, has good curative effect, no toxic and side effects, and has broad application prospects.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for secondary prevention of acute coronary syndrome after PCI. Background technique [0002] Coronary atherosclerotic heart disease (CHD) is the most common cardiovascular disease and one of the most common causes of death. CHD is further divided into two categories: acute coronary syndrome (ACS) and chronic ischemic syndrome (CIS). Among them, ACS is the most dangerous type of CHD and is often complicated by various cardiac diseases. Adverse vascular events (MACE) have a poor prognosis and bring a heavy burden to the patient's family and society. Therefore, how to reduce the morbidity, morbidity and mortality of ACS has always been the focus of people from all walks of life and clinicians. [0003] ACS refers to a group of clinical syndromes that are based on the rupture or erosion of unstable atherosclerotic plaq...

AI Technical Summary

Problems solved by technology

[0006] There is no report about a kind of traditional Chinese medicine composition used for secondary prevention after PCI of acute coronary syndrome according to the present invention